Can a bladder pill fix blood sugar? new trial explores surprising link

NCT ID NCT04666636

Recruiting now Disease control Sponsor: Philip Kern Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 33 times

Summary

This study tests whether mirabegron, a drug currently used for overactive bladder, can improve how the body handles sugar in people with prediabetes. Researchers will measure changes in glucose tolerance, body fat, and brown fat activity in 65 adults with prediabetes. The goal is to find a new way to control or delay the progression to type 2 diabetes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Kentucky
RECRUITING

Lexington, Kentucky, 40536, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

diabetes mellitus platelet-type bleeding disorder 10 prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREDIABETES PREDIABETES